Paper41009554
Insights into the Metabolic Adaptations of a Carbapenem-Resistant Klebsiella pneumoniae Strain on Exposure to Sublethal Concentrations of Ertapenem.
Jaén-Luchoro D and 5 others. Int J Mol Sci, 2025. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Insights into the Metabolic Adaptations of a Carbapenem-Resistant Klebsiella pneumoniae Strain on Exposure to Sublethal Concentrations of Ertapenem. Papers, record 41009554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41009554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Insights into the Metabolic Adaptations of a Carbapenem-Resistant Klebsiella pneumoniae Strain on Exposure to Sublethal Concentrations of Ertapenem.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Klebsiella pneumoniae | Major topic |
| Ertapenem | Major topic |
| Anti-Bacterial Agents | Major topic |
| Carbapenems | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Adaptation, Physiological | Major topic |
| Bacterial Proteins | |
| Proteome | |
| Proteomics | |
| Microbial Sensitivity Tests | |
| beta-Lactamases |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2016-06504 | Joint Programme Initiative -Anti-Microbial Resistance (JPIAMR) | PubMed | ||
| 205314021 | Centre for Antibiotic Resistance Research (CARe) | PubMed | ||
| ALFGBG-720761 | Swedish Government and the county councils agreement, the Avtal om Läkarutbildning och Forskning (ALF)-agreements | PubMed |
Source PubMed
References94
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 35489635 | Phage resistance mutation triggered by OmpC deficiency in Klebsiella pneumoniae induced limited fitness costs. | Microb Pathog | 2022 | https://conductscience.org/library/papers/35489635 | PubMed |
| 2 | 24451626 | InterProScan 5: genome-scale protein function classification. | Bioinformatics | 2014 | https://conductscience.org/library/papers/24451626 | PubMed |
| 3 | 39547536 | Development of disinfectant tolerance in Klebsiella pneumoniae. | J Hosp Infect | 2025 | https://conductscience.org/library/papers/39547536 | PubMed |
| 4 | 34872351 | OXA-23 β-Lactamase Overexpression in Acinetobacter baumannii Drives Physiological Changes Resulting in New Genetic Vulnerabilities. | mBio | 2021 | https://conductscience.org/library/papers/34872351 | PubMed |
| 5 | 33972250 | Trade-Offs between Antibacterial Resistance and Fitness Cost in the Production of Metallo-β-Lactamases by Enteric Bacteria Manifest as Sporadic Emergence of Carbapenem Resistance in a Clinical Setting. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/33972250 | PubMed |
| 6 | 28375512 | The Epidemiology of Carbapenem-Resistant Enterobacteriaceae: The Impact and Evolution of a Global Menace. | J Infect Dis | 2017 | https://conductscience.org/library/papers/28375512 | PubMed |
| 7 | 37069157 | Outbreak report of polymyxin-carbapenem-resistant Klebsiella pneumoniae causing untreatable infections evidenced by synergy tests and bacterial genomes. | Sci Rep | 2023 | https://conductscience.org/library/papers/37069157 | PubMed |
| 8 | 36289971 | A Systematic Review of the Effect of Therapeutic Drug Monitoring on Patient Health Outcomes during Treatment with Carbapenems. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36289971 | PubMed |
| 9 | 10858336 | Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. | Antimicrob Agents Chemother | 2000 | https://conductscience.org/library/papers/10858336 | PubMed |
| 10 | 36289999 | Molecular Characteristics and Quantitative Proteomic Analysis of Klebsiella pneumoniae Strains with Carbapenem and Colistin Resistance. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/36289999 | PubMed |
| 11 | 26042098 | Involvement of aph(3')-IIa in the formation of mosaic aminoglycoside resistance genes in natural environments. | Front Microbiol | 2015 | https://conductscience.org/library/papers/26042098 | PubMed |
| 12 | 39494517 | COG database update 2024. | Nucleic Acids Res | 2025 | https://conductscience.org/library/papers/39494517 | PubMed |
| 13 | 36622237 | Knockout of Targeted Plasmid-Borne β-Lactamase Genes in an Extended-Spectrum-β-Lactamase-Producing Escherichia coli Strain: Impact on Resistance and Proteomic Profile. | Microbiol Spectr | 2023 | https://conductscience.org/library/papers/36622237 | PubMed |
| 14 | 31730892 | A systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections. | Int J Antimicrob Agents | 2020 | https://conductscience.org/library/papers/31730892 | PubMed |
| 15 | 23542354 | A systematic quantitative proteomic examination of multidrug resistance in Acinetobacter baumannii. | J Proteomics | 2013 | https://conductscience.org/library/papers/23542354 | PubMed |
| 16 | 37744914 | Regulation of biofilm formation in Klebsiella pneumoniae. | Front Microbiol | 2023 | https://conductscience.org/library/papers/37744914 | PubMed |
| 17 | 24602950 | Frequency of Klebsiella pneumoniae carbapenemase (KPC)-producing and non-KPC-producing Klebsiella species contamination of healthcare workers and the environment. | Infect Control Hosp Epidemiol | 2014 | https://conductscience.org/library/papers/24602950 | PubMed |
| 18 | 33688212 | Characterization of Carbapenem-Resistant Klebsiella pneumoniae ST15 Clone Coproducing KPC-2, CTX-M-15 and SHV-28 Spread in an Intensive Care Unit of a Tertiary Hospital. | Infect Drug Resist | 2021 | https://conductscience.org/library/papers/33688212 | PubMed |
| 19 | 20452953 | The bacterial cell envelope. | Cold Spring Harb Perspect Biol | 2010 | https://conductscience.org/library/papers/20452953 | PubMed |
| 20 | 34234121 | A genomic surveillance framework and genotyping tool for Klebsiella pneumoniae and its related species complex. | Nat Commun | 2021 | https://conductscience.org/library/papers/34234121 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42197440 | KPC-2 Orchestrates Systemic Metabolic Rewiring to Facilitate Antibiotic Adaptation in Klebsiella pneumoniae. | Microorganisms | 2026 | https://conductscience.org/library/papers/42197440 | PubMed |
| 42191701 | Untargeted metabolomics reveals organism specific biomarkers of carbapenem resistance in Klebsiella pneumoniae and Escherichia coli. | NPJ Syst Biol Appl | 2026 | https://conductscience.org/library/papers/42191701 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41009554
GET https://conductscience.org/api/papers/v1/41009554/references?page=2